Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
O. V. Golovinskaya
Observed names:
Головинская О. В.,
Головинская О.В.
Institution:
Federal State Budgetary Institution ‘Scientific Centre for Expert Evaluation of Medicinal Products’ of the Ministry of Health of the Russian Federation (SCEEMP)
Observed institution:
Federal State Budgetary Institution ‘Scientific Centre for Expert Evaluation of Medicinal Products’ of the Ministry of Health of the Russian Federation (SCEEMP)
ORCID:
0000-0002-6966-9859
Observed ORCID:
0000-0002-6966-9859
OpenAlex ID:
A5098394727
General Characteristics of Adjuvants and Their Mechanism of Action (Part 1)
2020
·
N. A. Alpatova
, Zh. I. Avdeeva
, et al.
·
Biological Products Prevention Diagnosis Treatment
·
12
PDF
Implementation of the 3Rs Concept in Quality Control of Biologicals: Status and Prospects (Review)
2025
·
L. A. Gaiderova
, N. A. Alpatova
, et al.
·
Safety and Risk of Pharmacotherapy
·
8
General characteristics of adjuvants and their mechanisms of action (part 2)
2021
·
N. А. Alpatova
, Zh. I. Avdeeva
, et al.
·
Biological Products Prevention Diagnosis Treatment
·
4
PDF
Comparative Analysis of Dyes Used in the Assessment of Filgrastim Products Specific Activity by Biological in vitro Methods
2020
·
O. V. Golovinskaya
, M. L. Baykova
, et al.
·
Biological Products Prevention Diagnosis Treatment
·
4
PDF
Recommendations for Expounding Evaluation of Biological (Specific) Activity of Biotechnological Products in Product Specification Files
2018
·
O. V. Golovinskaya
, S. L. Lysikova
, et al.
·
Biological Products Prevention Diagnosis Treatment
·
1
PDF
Validation of an in vitro biological method for filgrastim potency assessment
2026
·
L. A. Gaiderova
, M. L. Baykova
, et al.
·
Biological Products Prevention Diagnosis Treatment
Expert Assessment of In Vitro Potency Assays for Monoclonal Antibody Preparations
2025
·
N. A. Alpatova
, O. V. Golovinskaya
, et al.
·
Ведомости Научного центра экспертизы средств медицинского применения
PDF
Реализация концепции 3Rs при контроле качества биологических препаратов: современное состояние и перспективы (обзор)
2025
·
Гайдерова Л. А.
, Алпатова Н. А.
, et al.
·
Safety and Risk of Pharmacotherapy
Potency evaluation of erythropoietin products: current status
2024
·
L. A. Gaiderova
, N. A. Alpatova
, et al.
·
Biological Products Prevention Diagnosis Treatment
PDF
Общая Характеристика Адъювантов И Механизм Их Действия (часть 2)
2021
·
Алпатова Н. А.
, Авдеева Ж. И.
, et al.
·
Biological Products Prevention Diagnosis Treatment
Show more works
View as search
Works count:
14
Citation count:
30
H-index:
4
I10-index:
1
Year
Topic
Type